EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Berberine and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Hope or Hype?

Ruth Nona iD, Eric Kalo iD

Pharmacology Research & Perspectives · 2026-08 · 14 (4)

DOI: 10.1002/prp2.70300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 15.07.2026. Verfasst von Ruth Nona und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Dentistry, James Cook University, Smithfield, Queensland, Australia. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[Extract] Berberine, an odorless isoquinoline alkaloid derived from the Berberis species, has recently gained significant public attention as a metabolic supplement. Its popularity has been amplified by non-medical messaging primarily through social media, where it is often promoted as “Nature's Ozempic”- a potential alternative to glucagon-like peptide-1 (GLP-1) receptor agonists. This framing is appealing, but it is also potentially misleading. In this commentary, we pose a sharper question: does the current evidence justify viewing berberine as a meaningful adjunct in metabolic dysfunction-associated steatotic liver disease (MASLD), or has enthusiasm outpaced the data?

Schlagwörter

Stichwörter der Autor:innen

MASLDberberinediabetesmediaweight loss

Autor:innen und Institutionen

  • College of Medicine and Dentistry, James Cook University, Smithfield, Queensland, Australia.

ORCID-Profile: Ruth Nona, Eric Kalo

Zitieren

APA

Nona, R., & Kalo, E. (2026). Berberine and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Hope or Hype?. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70300

Vancouver

Nona R, Kalo E. Berberine and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Hope or Hype?. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70300

BibTeX
@article{Nona2026,
  author = {Nona, Ruth and Kalo, Eric},
  title = {Berberine and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Hope or Hype?},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/prp2.70300}
}
Kostenlos starten →